Russell 2000 estimated to drop 83 stocks in December rebalance - Stephens
at seekingalpha.com (Thu, 29-Oct 3:44 PM)
Analyst Reiterates Buy on Elicio Therapeutics, Maintaining $23 Price Target as Subgroup Data Support Camupepimut’s Phase 3 Potential
at www.tipranks.com (Mon, 26-Oct 7:25 AM)